G / Genpact Limited - تصريحات هيئة الأوراق المالية والبورصات، التقرير السنوي، بيان الوكيل

جينباكت المحدودة
US ˙ NYSE ˙ BMG3922B1072

الإحصائيات الأساسية
LEI 529900OSEC6Q0L4L5B35
CIK 1398659
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Genpact Limited
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
August 11, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended June 30, 2025 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT LI

August 7, 2025 EX-99.1

Genpact Reports Second Quarter 2025 Results Net Revenues of $1.254 billion, Up 6.6% (6.2% constant currency)1 Data-Tech-AI Net Revenues of $599 million, Up 9.7% (9.5% constant currency)1 Digital Operations Net Revenues of $655 million, Up 4.0% (3.4%

Exhibit 99.1 Genpact Reports Second Quarter 2025 Results Net Revenues of $1.254 billion, Up 6.6% (6.2% constant currency)1 Data-Tech-AI Net Revenues of $599 million, Up 9.7% (9.5% constant currency)1 Digital Operations Net Revenues of $655 million, Up 4.0% (3.4% constant currency)1 Advanced Technology Solutions Net Revenues2 of $293 million, Up 17.3% Core Business Services Net Revenues2 of $962 mi

August 7, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 GENPACT LIMITED (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Numb

August 5, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2025 GENPACT LIMITED (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2025 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Numbe

July 1, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2025 GENPACT LIMITED (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2025 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number

May 28, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2025 GENPACT LIMITED (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2025 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number

May 12, 2025 EX-10.2

Form of 2025 Restricted Share Unit Issuance Agreement for executive officers under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Exhibit 10.2 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN RESTRICTED SHARE UNIT ISSUANCE AGREEMENT THIS RESTRICTED SHARE UNIT ISSUANCE AGREEMENT (the “Agreement”), dated as of (the “Award Date”), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the “Company”) and (“Participant”). To the extent not defined herein, all capitalized t

May 12, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended March 31, 2025 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT L

May 12, 2025 EX-10.3

Form of 2025 Performance Share Award Agreement for executive officers under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Exhibit 10.3 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN PERFORMANCE SHARE AWARD AGREEMENT THIS PERFORMANCE SHARE AWARD AGREEMENT (the “Agreement”), dated as of (the “Award Date”), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the “Company”) and (“Participant”). To the extent not defined herein, all capitalized terms in this A

May 12, 2025 EX-22.1

List of Issuers and Guarantor Subsidiaries

Exhibit 22.1 List of Issuers and Guarantor Subsidiaries This table sets forth the issuers and guarantors of the notes issued by Genpact Limited and its subsidiaries and the jurisdiction of incorporation or organization for each such entity. Entity Jurisdiction of Incorporation or Organization 1.750% Senior Notes due 2026 6.000% Senior Notes due 2029 Genpact Limited Bermuda Guarantor Guarantor Genp

May 7, 2025 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2025 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number)

May 7, 2025 EX-99.1

Genpact Reports First Quarter 2025 Results Net Revenues of $1.215 billion, Up 7.4% (8.3% constant currency)1 Data-Tech-AI Net Revenues of $582 million, Up 11.1% (11.7% constant currency)1 Digital Operations Net Revenues of $633 million, Up 4.2% (5.4%

Exhibit 99.1 Genpact Reports First Quarter 2025 Results Net Revenues of $1.215 billion, Up 7.4% (8.3% constant currency)1 Data-Tech-AI Net Revenues of $582 million, Up 11.1% (11.7% constant currency)1 Digital Operations Net Revenues of $633 million, Up 4.2% (5.4% constant currency)1 Diluted EPS of $0.73, Up 14%; Adjusted Diluted EPS2 of $0.84, Up 16% NEW YORK, May 7, 2025 — Genpact Limited (NYSE:

May 6, 2025 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Stat

April 9, 2025 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934               Filed by the Registrant ☒     Filed by a Party other than the Registrant  ☐                       Check the appropriate box:      ☐     Preliminary Proxy Statement      ☐     Confidential, for Use of th

April 9, 2025 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Stat

March 3, 2025 EX-19.1

enpact Limited Insider Trading P

Exhibit 19.1 Genpact Limited Insider Trading Policy and Procedures All directors, officers and employees of Genpact Limited or its subsidiaries (collectively, “Genpact” or the “Company”), as well as consultants to the Company, are subject to the provisions of this Insider Trading Policy and Procedures (the “Policies and Procedures”). These Policies and Procedures also apply to any person who share

March 3, 2025 EX-10.22

Employment Agreement by and between the Registrant and

Exhibit 10.22 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”), effective as of the date the last Party to sign the Agreement signs the same (the “Effective Date”), by and between Genpact Limited, a Bermuda limited exempted company (the “Company”), and Riju Vashisht (the “Executive” and, together with the Company, the “Parties”). WHEREAS, the Company or an affiliate of the Company

March 3, 2025 EX-10.21

Employment Agreement by and between the Registrant and Anil Nanduru, dated November 23, 2021.

Exhibit 10.21 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”), effective as of the date the last Party to sign the Agreement signs the same (the “Effective Date”), by and between Genpact Limited, a Bermuda limited exempted company (the “Company”), and Anil Nanduru (the “Executive” and, together with the Company, the “Parties”). WHEREAS, the Company or an affiliate of the Company

March 3, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2024. ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 001-33626 GENPACT LIMITED (Exact na

March 3, 2025 EX-21.1

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of the Registrant: Name: Jurisdiction of Incorporation: Genpact Argentina S.R.L. Argentina Genpact Australia Pty Ltd. Australia Headstrong (Australia) Pty Ltd. Australia Genpact Global (Bermuda) Limited Bermuda Genpact Global Holdings (Bermuda) Limited Bermuda Genpact Brasil Gestão de Processos Operacionais Ltda. Brazil Genpact Bulgaria EOOD Republic of Bulgaria Genpact C

March 3, 2025 EX-10.24

ated as of January 1, 2025 (incorporated by reference to Exhibit 10.24 to the Registra

Exhibit 10.24 AMENDMENT OF EMPLOYMENT AGREEMENT This AMENDMENT OF EMPLOYMENT AGREEMENT (this “Amendment”), dated as of January 1, 2025 (the “Effective Date”), by and between [Company Name] (the “Company”), and [Executive] (the “Executive” and, together with the Company, the “Parties”). WHEREAS, the Company and the Executive entered into an Employment Agreement on or about [Date] (the “Agreement”).

February 6, 2025 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2025 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

February 6, 2025 EX-99.1

Genpact Reports Full Year and Fourth Quarter 2024 Results 2024 Net Revenues of $4.77 billion, Up 6.5% (6.7% constant currency)1,2 2024 Data-Tech-AI Net Revenues of $2.23 billion, Up 6.9%1,2,3,4 2024 Digital Operations Net Revenues of $2.53 billion, U

Exhibit 99.1 Genpact Reports Full Year and Fourth Quarter 2024 Results 2024 Net Revenues of $4.77 billion, Up 6.5% (6.7% constant currency)1,2 2024 Data-Tech-AI Net Revenues of $2.23 billion, Up 6.9%1,2,3,4 2024 Digital Operations Net Revenues of $2.53 billion, Up 6.1% (6.5% constant currency)1,4 2024 Diluted EPS of $2.85, Down 16%; Adjusted Diluted EPS of $3.28, Up 10%5,6 Increases Quarterly Divi

November 12, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended September 30, 2024 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPA

November 7, 2024 EX-99.1

Genpact Reports Third Quarter 2024 Results Total Revenue of $1.21 billion, Up 7% (7% constant currency)1 Diluted EPS of $0.74, Up 16%; Adjusted Diluted EPS2 of $0.85, Up 12%

Exhibit 99.1 Genpact Reports Third Quarter 2024 Results Total Revenue of $1.21 billion, Up 7% (7% constant currency)1 Diluted EPS of $0.74, Up 16%; Adjusted Diluted EPS2 of $0.85, Up 12% NEW YORK, November 7, 2024 — Genpact Limited (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced financial results for the third quarter ended Se

November 7, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2024 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

August 9, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended June 30, 2024 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT LI

August 9, 2024 EX-22.1

List of Issuers and Guarantor Subsidiaries

Exhibit 22.1 List of Issuers and Guarantor Subsidiaries This table sets forth the issuers and guarantors of the notes issued by Genpact Limited and its subsidiaries and the jurisdiction of incorporation or organization for each such entity. Entity Jurisdiction of Incorporation or Organization 3.375% Senior Notes due 2024 1.750% Senior Notes due 2026 6.000% Senior Notes due 2029 Genpact Limited Ber

August 8, 2024 EX-99.1

Genpact Reports Second Quarter 2024 Results Total Revenue of $1.18 billion, Up 6% (7% constant currency)1 Diluted EPS of $0.67, Up 6%; Adjusted Diluted EPS2 of $0.79, Up 10%

Exhibit 99.1 Genpact Reports Second Quarter 2024 Results Total Revenue of $1.18 billion, Up 6% (7% constant currency)1 Diluted EPS of $0.67, Up 6%; Adjusted Diluted EPS2 of $0.79, Up 10% NEW YORK, August 8, 2024 — Genpact Limited (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced financial results for the second quarter ended Jun

August 8, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Numb

August 8, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2024 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Numb

June 6, 2024 SC 13G/A

G / Genpact Limited / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 15 )* Genpact Limited (Name of Issuer) Common Stock (Title of Class of Securities) G3922B107 (CUSIP Number) May 31, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i

June 4, 2024 EX-5.3

Schedule 1 Part 1 The Documents

Exhibit 5.3 Bermuda Office Appleby (Bermuda) Limited Canon's Court 22 Victoria Street PO Box HM 1179 Hamilton HM EX Bermuda Tel +1 441 295 2244 Genpact Luxembourg S.à r.l. 12F, Rue Guillaume Kroll L-1882 Luxembourg and Genpact USA, Inc. 521 Fifth Avenue, 14th Floor New York, NY 10175 and Genpact Limited Canons Court 22 Victoria Street Hamilton, HM10 Bermuda and Computershare Trust Company, Nationa

June 4, 2024 EX-1.1

GENPACT LUXEMBOURG S.À R.L. GENPACT USA, INC. GENPACT LIMITED $400,000,000 6.000% Senior Notes due 2029 Underwriting Agreement

Exhibit 1.1 GENPACT LUXEMBOURG S.À R.L. GENPACT USA, INC. GENPACT LIMITED $400,000,000 6.000% Senior Notes due 2029 Underwriting Agreement May 30, 2024 Citigroup Global Markets Inc. Goldman Sachs & Co. LLC Morgan Stanley & Co. LLC As Representatives of the several Underwriters c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 c/o Goldman Sachs & Co. LLC 200 West Stree

June 4, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2024 GENPACT LIMITED (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2024 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number

June 4, 2024 EX-4.2

Second Supplemental Indenture, dated as of June 4, 2024, by and among the Registrant, Genpact Luxembourg S.à r.l., Genpact USA, Inc. and Computershare Trust Company, National Association (as successor to Wells Fargo Bank, National Association), as trustee, to the Base Indenture dated as of March 26, 2021 (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K (File No. 001-33626) filed with the SEC on June 4, 2024).

Exhibit 4.2 EXECUTION VERSION] GENPACT LUXEMBOURG S.À R.L. and GENPACT USA, INC. as the Issuers, GENPACT LIMITED, as Guarantor, and COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION, as successor to WELLS FARGO BANK, NATIONAL ASSOCIATION, as the Trustee SECOND SUPPLEMENTAL INDENTURE Dated as of June 4, 2024 to INDENTURE Dated as of March 26, 2021 Relating to $400,000,000 of 6.000% Senior Notes due

June 3, 2024 424B2

PROSPECTUS SUPPLEMENT (To Prospectus Dated May 25, 2022)

TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(2) Registration Nos. 333-265204 333-265204-01 333-265204-02 PROSPECTUS SUPPLEMENT (To Prospectus Dated May 25, 2022) $400,000,000   Genpact Luxembourg S.à r.l. Genpact USA, Inc. 6.000% Senior Notes due 2029 Guaranteed by Genpact Limited Genpact Luxembourg S.à r.l., a private limited liability company (société à responsabilité limitée) organized under

June 3, 2024 EX-FILING FEES

Calculation of Filing Fee Tables (Form Type) Genpact Limited Genpact Luxembourg S.à r.l. Genpact USA, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 Calculation of Filing Fee Tables 424(b)(2) (Form Type) Genpact Limited Genpact Luxembourg S.

May 30, 2024 FWP

Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Dated May 30, 2024 Registration Number 333-265204 333-265204-01 333-265204-02 GENPACT LUXEMBOURG S.À R.L. GENPACT USA, INC. GENPACT LIMITED $400,000,000 6.000% Senior Notes due 2029 Pricing Te

Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Dated May 30, 2024 Registration Number 333-265204 333-265204-01 333-265204-02 GENPACT LUXEMBOURG S.

May 28, 2024 424B5

SUBJECT TO COMPLETION, DATED MAY 28, 2024 PRELIMINARY PROSPECTUS SUPPLEMENT (To Prospectus Dated May 25, 2022)

TABLE OF CONTENTS The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed.

May 10, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended March 31, 2024 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT L

May 10, 2024 EX-10.1

Form of 2024 Restricted Share Unit Issuance Agreement for executive officers under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Exhibit 10.1 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN RESTRICTED SHARE UNIT ISSUANCE AGREEMENT THIS RESTRICTED SHARE UNIT ISSUANCE AGREEMENT (the “Agreement”), dated as of (the “Award Date”), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the “Company”) and (“Participant”). To the extent not defined herein, all capitalized t

May 10, 2024 EX-10.2

Agreement for executive officers under the Genpact Limited 2017 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.

Exhibit 10.2 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN PERFORMANCE SHARE AWARD AGREEMENT THIS PERFORMANCE SHARE AWARD AGREEMENT (the “Agreement”), dated as of (the “Award Date”), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the “Company”) and (“Participant”). To the extent not defined herein, all capitalized terms in this A

May 9, 2024 EX-99.1

Genpact Reports First Quarter 2024 Results Total Revenue of $1.13 billion, Up 4%1,2,3 Diluted EPS of $0.64, Up 12%; Adjusted Diluted EPS4 of $0.73, Up 7%

Exhibit 99.1 Genpact Reports First Quarter 2024 Results Total Revenue of $1.13 billion, Up 4%1,2,3 Diluted EPS of $0.64, Up 12%; Adjusted Diluted EPS4 of $0.73, Up 7% NEW YORK, May 9, 2024 — Genpact Limited (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced financial results for the first quarter ended March 31, 2024. “Results fo

May 9, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number)

May 8, 2024 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2024 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number)

April 10, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy St

March 20, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Stat

March 20, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D

February 29, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023. ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 001-33626 GENPACT LIMITED (Exact na

February 29, 2024 EX-10.23

between Genpact India Private Limited and Piyush Mehta, dated November 24, 2021

Exhibit 10.23 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this “Agreement”), effective as of the date the last Party to sign the agreement signs the same (the “Effective Date”), by and between Genpact India Private Limited (the “Company”), and Piyush Mehta (the “Executive” and, together with the Company, the “Parties”). WHEREAS, the Executive has been employed by the Company pursuant to that c

February 29, 2024 EX-21.1

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of the Registrant: Name: Jurisdiction of Incorporation: Genpact Argentina S.R.L. Argentina Genpact Australia Pty Ltd. Australia Headstrong (Australia) Pty Ltd. Australia Genpact Global (Bermuda) Limited Bermuda Genpact Global Holdings (Bermuda) Limited Bermuda Genpact Brasil Gestão de Processos Operacionais Ltda. Brazil Genpact Bulgaria EOOD Republic of Bulgaria Genpact C

February 29, 2024 EX-97.1

Compensation Clawback Policy

Exhibit 97.1 GENPACT LIMITED Compensation Clawback Policy This Compensation Clawback Policy (this “Policy”), adopted by Genpact Limited (the “Company”), relates to the Company’s right to recover compensation previously paid to specified employees in certain circumstances, including the recovery of Erroneously Awarded Compensation (as defined below) in accordance with Section 303A.14 of the New Yor

February 13, 2024 SC 13G/A

G / Genpact Limited / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01005-genpactltd.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Genpact Ltd Title of Class of Securities: Common Stock CUSIP Number: G3922B107 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pu

February 8, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2024 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

February 8, 2024 EX-99.1

Genpact Reports Full Year and Fourth Quarter 2023 Results 2023 Total Revenue of $4.48 billion, Up 2% (3% constant currency)1,2 2023 Digital Operations Services Revenue of $2.48 billion, Up 3 % (4% constant currency)1 2023 Data-Tech-AI Services Revenu

Exhibit 99.1 Genpact Reports Full Year and Fourth Quarter 2023 Results 2023 Total Revenue of $4.48 billion, Up 2% (3% constant currency)1,2 2023 Digital Operations Services Revenue of $2.48 billion, Up 3 % (4% constant currency)1 2023 Data-Tech-AI Services Revenue of $1.99 billion, Up 2%1,2,3 2023 Diluted EPS of $3.41, Up 81%; Adjusted Diluted EPS4,5 of $2.98, Up 9% Increases Quarterly Dividend by

February 8, 2024 SC 13G/A

G / Genpact Limited / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 14 )* Genpact Limited (Name of Issuer) Common Stock (Title of Class of Securities) G3922B107 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched

November 30, 2023 EX-10.1

Separation Agreement and General Release, dated as of November 29, 2023, by and between the Registrant and Kathryn Stein (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K (File No. 001-33626) filed with the SEC on November 30, 2023).

Exhibit 10.1 PLEASE READ CAREFULLY AND CONSULT WITH AN ATTORNEY BEFORE SIGNING THIS SEPARATION AGREEMENT AND GENERAL RELEASE INCLUDES A RELEASE OF ANY AND ALL KNOWN AND UNKNOWN CLAIMS AGAINST GENPACT IF YOU DO NOT UNDERSTAND THE DOCUMENT FULLY, DO NOT SIGN IT SEPARATION AGREEMENT AND GENERAL RELEASE This SEPARATION AGREEMENT and GENERAL RELEASE (the “Agreement”) is made this 29th day of November 2

November 30, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2023 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File N

November 9, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended September 30, 2023 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPA

November 8, 2023 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2023 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

November 8, 2023 EX-10.1

Amended and Restated Employment Agreement, dated as of November 8, 2023, by and between the Registrant and and Balkrishan Kalra (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-33626) filed with the SEC on November 8, 2023).

EX-10.1 2 ef20014275ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), by and between Genpact Limited, a Bermuda limited exempted company (the “Company”), and Balkrishan Kalra (the “Executive” and, together with the Company, the “Parties”) is made as of November 8, 2023 and effective as of February 9, 20

November 8, 2023 EX-99.1

Genpact Announces CEO Succession Plan Tiger Tyagarajan to retire, BK Kalra to assume CEO role

Exhibit 99.1 Genpact Announces CEO Succession Plan Tiger Tyagarajan to retire, BK Kalra to assume CEO role NEW YORK, November 8, 2023 – Genpact (NYSE: G), a global professional services firm focused on delivering outcomes that transform businesses, today announced a leadership succession plan. “Tiger” Tyagarajan, President and Chief Executive Officer, has informed the Board of Directors of his int

November 8, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2023 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

November 8, 2023 EX-99.1

Genpact Reports Third Quarter 2023 Results Total revenue of $1.14 billion, Up 2% 1,2 Digital Operations services revenue of $636 million, Up 6% 1 Data-Tech-AI services revenue of $500 million, Down 2% 1,2 Diluted EPS of $0.64, Up 25%; Adjusted Dilute

Exhibit 99.1 Genpact Reports Third Quarter 2023 Results Total revenue of $1.14 billion, Up 2% 1,2 Digital Operations services revenue of $636 million, Up 6% 1 Data-Tech-AI services revenue of $500 million, Down 2% 1,2 Diluted EPS of $0.64, Up 25%; Adjusted Diluted EPS3 of $0.76, Up 1% NEW YORK, November 8, 2023 — Genpact Limited (NYSE: G), a global professional services firm focused on delivering

August 9, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended June 30, 2023 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT LI

August 9, 2023 EX-99.1

Genpact Reports Second Quarter 2023 Results Total revenue of $1.106 billion, Up 2% (3% constant currency)1,2 Data-Tech-AI services revenue of $501 million, Up 2% (3% constant currency) 1,2 Digital Operations services revenue of $605 million, Up 1% (2

Exhibit 99.1 Genpact Reports Second Quarter 2023 Results Total revenue of $1.106 billion, Up 2% (3% constant currency)1,2 Data-Tech-AI services revenue of $501 million, Up 2% (3% constant currency) 1,2 Digital Operations services revenue of $605 million, Up 1% (2% constant currency)1 Diluted EPS of $0.63, Up 66%; Adjusted Diluted EPS3 of $0.72, Up 3% NEW YORK, August 9, 2023 — Genpact Limited (NYS

August 9, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 GENPACT LIMITED (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Numb

May 10, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended March 31, 2023 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT L

May 10, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number

May 10, 2023 EX-99.1

Genpact Reports First Quarter 2023 Results Total revenue of $1.09 billion, Up 2% (4% constant currency)1,2 Data-Tech-AI services revenue of $485 million, Up 4% (6% constant currency)1,2 Digital Operations services revenue of $604 million, Up 0.4% (3%

Exhibit 99.1 Genpact Reports First Quarter 2023 Results Total revenue of $1.09 billion, Up 2% (4% constant currency)1,2 Data-Tech-AI services revenue of $485 million, Up 4% (6% constant currency)1,2 Digital Operations services revenue of $604 million, Up 0.4% (3% constant currency)1 Diluted EPS of $0.57, Up 12%; Adjusted Diluted EPS3 of $0.68, Up 13% NEW YORK, May 10, 2023 — Genpact Limited (NYSE:

May 10, 2023 EX-10.1

Agreement for executive officers under the Genpact Limited 2017 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit

Exhibit 10.1 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN RESTRICTED SHARE UNIT ISSUANCE AGREEMENT THIS RESTRICTED SHARE UNIT ISSUANCE AGREEMENT (the “Agreement”), dated as of (the “Award Date”), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the “Company”) and (“Participant”). To the extent not defined herein, all capitalized t

May 10, 2023 EX-10.2

Agreement for executive officers under the Genpact Limited 2017 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit

Exhibit 10.2 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN PERFORMANCE SHARE AWARD AGREEMENT THIS PERFORMANCE SHARE AWARD AGREEMENT (the “Agreement”), dated as of (the “Award Date”), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the “Company”) and (“Participant”). To the extent not defined herein, all capitalized terms in this A

May 8, 2023 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number)

March 21, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy St

March 21, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D

March 1, 2023 EX-10.16

Exhibit 10.16 to the Registrant's Annual Report on Form 10-K (File No. 001-33626) filed with the SEC on

Exhibit 10.16 Amendment 2022-1 Genpact LLC Executive Deferred Compensation Plan WHEREAS, the Genpact LLC (the “Company”) maintains the Genpact LLC Executive Deferred Compensation Plan (the “Plan”); and WHEREAS, pursuant to Article 9 of the Plan, subject to the applicable requirements of Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”), the Member (as defined in the Pl

March 1, 2023 EX-21.1

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of the Registrant: Name: Jurisdiction of Incorporation: Genpact Australia Pty Ltd. Australia Headstrong (Australia) Pty Ltd. Australia Genpact Global (Bermuda) Limited Bermuda Genpact Global Holdings (Bermuda) Limited Bermuda Genpact Brasil Gestão de Processos Operacionais Ltda. Brazil Genpact Bulgaria EOOD Republic of Bulgaria Genpact Canada Services Company Canada Heads

March 1, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2022. ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 001-33626 GENPACT LIMITED (Exact na

February 9, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2023 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

February 9, 2023 EX-99.1

Genpact Reports Full Year and Fourth Quarter 2022 Results 2022 Total Revenue of $4.37 billion, Up 9% (11% constant currency)1,2 2022 Diluted EPS of $1.88, Down 2%; Adjusted Diluted EPS3 of $2.74, Up 12% Increases Quarterly Dividend by 10% and Share R

Exhibit 99.1 Genpact Reports Full Year and Fourth Quarter 2022 Results 2022 Total Revenue of $4.37 billion, Up 9% (11% constant currency)1,2 2022 Diluted EPS of $1.88, Down 2%; Adjusted Diluted EPS3 of $2.74, Up 12% Increases Quarterly Dividend by 10% and Share Repurchase Authorization by $500 million NEW YORK, February 9, 2023 — Genpact Limited (NYSE: G), a global professional services firm focus

February 9, 2023 SC 13G/A

G / Genpact Ltd / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0973-genpactltd.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: Genpact Ltd. Title of Class of Securities: Common Stock CUSIP Number: G3922B107 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pu

February 7, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2023 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

February 6, 2023 SC 13G/A

G / Genpact Ltd / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13 )* Genpact Limited (Name of Issuer) Common Stock (Title of Class of Securities) G3922B107 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched

December 16, 2022 EX-10.1

Wells Fargo Bank, National Association, as administrative agent, swingline lender, term lender, an issuing bank and a revolving lender, and the other parties thereto (incorporated by reference to Exhibit

Exhibit 10.1 Execution Version SECOND AMENDED & RESTATED CREDIT AGREEMENT dated as of December 13, 2022 among GENPACT USA, INC., GENPACT GLOBAL HOLDINGS (BERMUDA) LIMITED, and GENPACT LUXEMBOURG S.? R.L., as the Borrowers, GENPACT LIMITED, as Holdings, WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, Swingline Lender, a Term Lender, an Issuing Bank and a Revolving Lender, and The O

December 16, 2022 8-K

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 13, 2022 GENPACT LIMITED (Exact Name of Registrant as Specified in Charter) Bermuda 001-33626 98-0533350 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

November 9, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended September 30, 2022 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPA

November 9, 2022 EX-99.1

Genpact Reports Third Quarter 2022 Results Total revenue of $1.111 billion, Up 9% (12% on a constant currency basis)1,2 Data-Tech-AI services revenue of $510 million, Up 19% (21% on a constant currency basis) 1,2 Digital Operations services revenue o

Exhibit 99.1 Genpact Reports Third Quarter 2022 Results Total revenue of $1.111 billion, Up 9% (12% on a constant currency basis)1,2 Data-Tech-AI services revenue of $510 million, Up 19% (21% on a constant currency basis) 1,2 Digital Operations services revenue of $601 million, Up 2% (6% on a constant currency basis)1 Diluted EPS of $0.51, Down 4%; Adjusted Diluted EPS3 of $0.75, Up 14% NEW YORK,

November 9, 2022 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2022 GENPACT LIMITED

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2022 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

August 9, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended June 30, 2022 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT LI

August 4, 2022 EX-99.1

Genpact Reports Second Quarter 2022 Results Total revenue of $1.089 billion, Up 10% (12% on a constant currency basis)1,2 Data-Tech-AI services revenue of $489 million, Up 20% (22% on a constant currency basis) 1,2 Digital Operations services revenue

Exhibit 99.1 Genpact Reports Second Quarter 2022 Results Total revenue of $1.089 billion, Up 10% (12% on a constant currency basis)1,2 Data-Tech-AI services revenue of $489 million, Up 20% (22% on a constant currency basis) 1,2 Digital Operations services revenue of $601 million, Up 3% (5% on a constant currency basis)1 Diluted EPS of $0.38, Down 28%; Adjusted Diluted EPS3 of $0.70, Up 6% NEW YORK

August 4, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2022 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Numb

May 25, 2022 EX-22.1

Exhibit 22.1 to the Registrant’s Registration Statement on Form S-3ASR (File No. 333-265204) filed with the SEC on May 25, 2022).

Exhibit 22.1 List of Issuers and Guarantor Subsidiaries This table sets forth the issuers and guarantors of the notes issued by Genpact Limited and its subsidiaries and the jurisdiction of incorporation or organization for each such entity. Entity Jurisdiction of Incorporation or Organization 3.375% Senior Notes due 2024 1.750% Senior Notes due 2026 Genpact Limited Bermuda Guarantor Guarantor Genp

May 25, 2022 EX-4.1

Form of Senior Indenture of Genpact Limited

Exhibit 4.1 GENPACT LIMITED as Issuer, and [], as Trustee Indenture Dated as of [] Senior Debt Securities TABLE OF CONTENTS Page ARTICLE ONE DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 101. Definitions 1 SECTION 102. Compliance Certificates and Opinions 6 SECTION 103. Form of Documents Delivered to Trustee 7 SECTION 104. Acts of Holders; Record Dates 7 SECTION 105. Notices, E

May 25, 2022 EX-4.2

Form of Subordinated Indenture of Genpact Limited

Exhibit 4.2 GENPACT LIMITED as Issuer, and [], as Trustee Indenture Dated as of [] Subordinated Debt Securities TABLE OF CONTENTS Page ARTICLE ONE DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 101. Definitions 1 SECTION 102. Compliance Certificates and Opinions 7 SECTION 103. Form of Documents Delivered to Trustee 7 SECTION 104. Acts of Holders; Record Dates 8 SECTION 105. Noti

May 25, 2022 EX-FILING FEES

Calculation of Filing Fee Table

EX-FILING FEES 9 d340238dexfilingfees.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Genpact Limited (Exact Name of Registrant as Specified in its Charter) Genpact Luxembourg S.à r.l. (Exact Name of Registrant as Specified in its Charter) Genpact USA, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1—Newly Registered Securities and Carry Forw

May 25, 2022 EX-5.3

Consent of Appleby (Bermuda) Limited (included in Exhibit 5.3)

Exhibit 5.3 Genpact Limited Canon?s Court 22 Victoria Street Hamilton HM12 Bermuda and Genpact Luxembourg S.? r.l. 12F, Rue Guillaume Kroll L-1882 Luxembourg and Genpact USA, Inc. 1155 6th Avenue 4th Floor, New York New York, 10036 Email [email protected] Direct Dial +1 441 298 3559 Direct Fax +1 441 298 3469 Tel +1 441 295 2244 Fax +1 441 292 8666 Your Ref Appleby Ref 132386.0032/JW/ CM/K

May 25, 2022 S-3ASR

As filed with the Securities and Exchange Commission on May 25, 2022

Table of Contents As filed with the Securities and Exchange Commission on May 25, 2022 Registration No.

May 24, 2022 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2022 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number

May 20, 2022 EX-FILING FEES

Filing Fee Tables

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Genpact Limited (Exact Name of Registrant as Specified in its Charter) Table 1?Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Shares, par value $0.

May 20, 2022 S-8

As filed with the Securities and Exchange Commission on May 20, 2022

As filed with the Securities and Exchange Commission on May 20, 2022 Registration No.

May 10, 2022 EX-10.1

Form of 2022 Performance Share Award Agreement for executive officers under the Genpact Limited 2017 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (File No. 001-33626) filed with the SEC on May 10, 2022).

Exhibit 10.1 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN PERFORMANCE SHARE AWARD AGREEMENT THIS PERFORMANCE SHARE AWARD AGREEMENT (the ?Agreement?), dated as of (the ?Award Date?), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the ?Company?) and (?Participant?). To the extent not defined herein, all capitalized terms in this A

May 10, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended March 31, 2022 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT L

May 5, 2022 EX-99.1

Genpact Reports First Quarter 2022 Results Total Revenue of $1.1 billion, Up 13% (14% on a constant currency basis)1 Global Client Revenue of $973 million, Up 14% (15% on a constant currency basis)1 Diluted EPS of $0.51, Up 9%; Adjusted Diluted EPS2

Exhibit 99.1 Genpact Reports First Quarter 2022 Results Total Revenue of $1.1 billion, Up 13% (14% on a constant currency basis)1 Global Client Revenue of $973 million, Up 14% (15% on a constant currency basis)1 Diluted EPS of $0.51, Up 9%; Adjusted Diluted EPS2 of $0.60, Up 2% NEW YORK, May 5, 2022 ? Genpact Limited (NYSE: G), a global professional services firm focused on delivering digital tran

May 5, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2022 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number)

April 14, 2022 SC 13G/A

G / Genpact Ltd / BROWN ADVISORY INC - BROWN ADVISORY INCORPORATED Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10)* GENPACT LTD. (Name of Issuer) (Title of Class of Securities) G3922B107 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X]

April 6, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

April 6, 2022 DEF 14A

Genpact Limited 2017 Omnibus Incentive Compensation Plan (as amended and restated April 5, 2022)(incorporated by reference to Exhibit 1 to the Registrant’s Proxy Statement on Schedule 14A (File No. 001-33626) filed with the SEC on April 6, 2022).

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ? Filed by the Registrant?? ? ? Filed by a Party other than the Registrant??? ? ? Check the appropriate box: ? ? ?? ? ? Preliminary Proxy Statement ? ? ?? ? ? Confidential, for Use of the Commission Only (as permitte

March 1, 2022 EX-21.1

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of the Registrant: Name: Jurisdiction of Incorporation: Genpact Australia Pty Ltd. Australia Headstrong (Australia) Pty Ltd. Australia Genpact Global (Bermuda) Limited Bermuda Genpact Global Holdings (Bermuda) Limited Bermuda Genpact Brasil Gest?o de Processos Operacionais Ltda. Brazil Genpact Bulgaria EOOD Bulgaria Genpact Canada Services Company Canada Headstrong Canada

March 1, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2021. ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 001-33626 GENPACT LIMITED (Exact na

February 11, 2022 EX-99.1

Genpact Reports Full Year and Fourth Quarter 2021 Results 2021 Total Revenue of $4.0 billion, Up 8% (7% on a constant currency basis)1 2021 Global Client Revenue of $3.6 billion, Up 12% (11% on a constant currency basis)1, 2 2021 Diluted EPS of $1.91

Exhibit 99.1 Genpact Reports Full Year and Fourth Quarter 2021 Results 2021 Total Revenue of $4.0 billion, Up 8% (7% on a constant currency basis)1 2021 Global Client Revenue of $3.6 billion, Up 12% (11% on a constant currency basis)1, 2 2021 Diluted EPS of $1.91, Up 22%; Adjusted Diluted EPS3 of $2.45, Up 16% Quarterly Cash Dividend Increased by 16% NEW YORK, February 11, 2022 ? Genpact Limited (

February 11, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2022 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File N

February 10, 2022 SC 13G/A

G / Genpact Ltd / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: Genpact Ltd. Title of Class of Securities: Common Stock CUSIP Number: G3922B107 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1

February 4, 2022 SC 13G/A

G / Genpact Ltd / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12 )* Genpact Limited (Name of Issuer) Common Stock (Title of Class of Securities) G3922B107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched

December 3, 2021 8-K

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2021 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File N

December 3, 2021 EX-10.3

Amendment Agreement between Headstrong Canada Company and Darren Saumur, dated November 30,2021 (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K (File No.001-33626) filed with the SEC on December 3, 2021).

Exhibit 10.3 AMENDMENT OF EMPLOYMENT AGREEMENT This AMENDMENT OF EMPLOYMENT AGREEMENT (this ?Amendment Agreement?), effective as of the date the last Party to sign the Amendment Agreement signs the same (the ?Effective Date?), by and between Headstrong Canada Company (f/k/a Headstrong Canada Limited) (the ?Company?), and Darren Saumur (the ?Employee? and, together with the Company, the ?Parties?).

December 3, 2021 EX-10.2

Employment Agreement between the Registrant and Kathryn Stein, dated November 30, 2021 (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No. 001-33626) filed with the SEC on December 3, 2021).

Exhibit 10.2 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this ?Agreement?), effective as of the date the last Party to sign the Agreement signs the same (the ?Effective Date?), by and between Genpact Limited, a Bermuda limited exempted company (the ?Company?), and Kathryn Vanpelt Stein (the ?Executive? and, together with the Company, the ?Parties?). WHEREAS, the Company or an affiliate of the

December 3, 2021 EX-10.1

Employment Agreement between the Registrant and Balkrishan Kalra, dated November 30, 2021 (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.001-33626) filed with the SEC on December 3, 2021).

Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this ?Agreement?), effective as of the date the last Party to sign the Agreement signs the same (the ?Effective Date?), by and between Genpact Limited, a Bermuda limited exempted company (the ?Company?), and Balkrishan Kalra (the ?Executive? and, together with the Company, the ?Parties?). WHEREAS, the Company or an affiliate of the Compa

November 9, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended September 30, 2021 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPA

November 9, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2021 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

November 9, 2021 EX-99.1

Genpact Reports Third Quarter 2021 Results Total Revenue of $1.02 billion, Up 9% (8% on a constant currency basis)1 Global Client Revenue of $921 million, Up 12% (11% on a constant currency basis)1, 2 Diluted EPS of $0.53, Up 23%; Adjusted Diluted EP

Exhibit 99.1 Genpact Reports Third Quarter 2021 Results Total Revenue of $1.02 billion, Up 9% (8% on a constant currency basis)1 Global Client Revenue of $921 million, Up 12% (11% on a constant currency basis)1, 2 Diluted EPS of $0.53, Up 23%; Adjusted Diluted EPS3 of $0.66, Up 18% NEW YORK, November 9, 2021 ? Genpact Limited (NYSE: G), a global professional services firm focused on delivering dig

August 9, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended June 30, 2021 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT LI

August 9, 2021 EX-10.5

Form of Restricted Share Unit Issuance Agreement for non-employee directors under the Genpact Limited 2017 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.5 to the Registrant’s

Exhibit 10.5 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN RESTRICTED SHARE UNIT ISSUANCE AGREEMENT THIS RESTRICTED SHARE UNIT ISSUANCE AGREEMENT (the ?Agreement?), dated as of (the ?Award Date?), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the ?Company?) and (?Participant?). To the extent not defined herein, all capitalized t

August 5, 2021 EX-99.1

Genpact Reports Second Quarter 2021 Results Total Revenue of $988 million, Up 10% (7% on a constant currency basis)1 Global Client Revenue of $893 million, Up 14% (11% on a constant currency basis)1,2 Diluted EPS of $0.53, Up 66%; Adjusted Diluted EP

Exhibit 99.1 ` Genpact Reports Second Quarter 2021 Results Total Revenue of $988 million, Up 10% (7% on a constant currency basis)1 Global Client Revenue of $893 million, Up 14% (11% on a constant currency basis)1,2 Diluted EPS of $0.53, Up 66%; Adjusted Diluted EPS3 of $0.66, Up 27% Raises Outlook for Revenue, Adjusted Operating Income Margin and Adjusted Diluted EPS NEW YORK, August 5, 2021 ? Ge

August 5, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2021 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Numb

July 22, 2021 EX-10.1

Employment Agreement between the Registrant and Michael Weiner dated July 16, 2021 (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-33626) filed with the SEC on July 22, 2021).

Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this ?Agreement?), dated as of July 16, 2021 and effective as of August 2, 2021 (the ?Effective Date?), by and between Genpact Limited, a Bermuda limited exempted company (the ?Company?), and Michael Weiner (the ?Executive? and, together with the Company, the ?Parties?). WHEREAS, the Company or an affiliate of the Company desires to empl

July 22, 2021 8-K

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2021 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Numbe

July 22, 2021 EX-10.2

Agreement for executive officers under the Genpact Limited 2017 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit

Exhibit 10.2 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN SHARE OPTION AGREEMENT THIS SHARE OPTION AGREEMENT (the ?Agreement?), dated as of (the ?Date of Grant?), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the ?Company?), and (?Participant?). R E C I T A L S: WHEREAS, the Company has adopted the Genpact Limited 2017 Omnibus

July 22, 2021 EX-10.3

Form of 2021 Performance Share Award Agreement for executive officers under the Genpact Limited 2017 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K (File No. 001-33626) filed with the SEC on July 22, 2021).

Exhibit 10.3 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN PERFORMANCE SHARE AWARD AGREEMENT THIS PERFORMANCE SHARE AWARD AGREEMENT (the ?Agreement?), dated as of (the ?Award Date?), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the ?Company?) and (?Participant?). To the extent not defined herein, all capitalized terms in this A

July 22, 2021 EX-10.4

Form of 2021 RSU Award Agreement for executive officers under the Genpact Limited 2017 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.4 to the Registrant’s Current Report on Form 8-K (File No. 001-33626) filed with the SEC on July 22, 2021).

Exhibit 10.4 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN RESTRICTED SHARE UNIT ISSUANCE AGREEMENT THIS RESTRICTED SHARE UNIT ISSUANCE AGREEMENT (the ?Agreement?), dated as of (the ?Award Date?), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the ?Company?) and (?Participant?). To the extent not defined herein, all capitalized t

May 11, 2021 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2021 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number)

May 10, 2021 EX-99.1

Genpact Reports First Quarter 2021 Results Total Revenue of $946 million, Up 2.5% (1% on a constant currency basis)1 Global Client Revenue of $853 million, Up 6% (5% on a constant currency basis)1, 2 Diluted EPS of $0.47, Up 7%; Adjusted Diluted EPS3

Exhibit 99.1 Genpact Reports First Quarter 2021 Results Total Revenue of $946 million, Up 2.5% (1% on a constant currency basis)1 Global Client Revenue of $853 million, Up 6% (5% on a constant currency basis)1, 2 Diluted EPS of $0.47, Up 7%; Adjusted Diluted EPS3 of $0.59, Up 11% Repurchased $134 million of shares at an average price of $40.68 per share NEW YORK, May 10, 2021 ? Genpact Limited (NY

May 10, 2021 EX-22.1

List of Issuers and Guarantor Subsidiaries (incorporated by reference to Exhibit 22.1 to the Registrant’s Quarterly Report on Form 10-Q (File No. 001-33626) filed with the SEC on May

Exhibit 22.1 List of Issuers and Guarantor Subsidiaries This table sets forth the issuers and guarantors of the notes issued by Genpact Limited and its subsidiaries and the jurisdiction of incorporation or organization for each such entity. Entity Jurisdiction of Incorporation or Organization 3.70% Senior Notes due 2022 3.375% Senior Notes due 2024 1.750% Senior Notes due 2026 Genpact Limited Berm

May 10, 2021 EX-10.2

Form of Performance Share Award Agreement under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Exhibit 10.2 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN PERFORMANCE SHARE AWARD AGREEMENT THIS PERFORMANCE SHARE AWARD AGREEMENT (the ?Agreement?), dated as of (the ?Award Date?), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the ?Company?) and (?Participant?). To the extent not defined herein, all capitalized terms in this A

May 10, 2021 EX-10.1

Form of Share Option Agreement under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

Exhibit 10.1 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN SHARE OPTION AGREEMENT THIS SHARE OPTION AGREEMENT (the ?Agreement?), dated as of (the ?Date of Grant?), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the ?Company?), and (?Participant?). R E C I T A L S: WHEREAS, the Company has adopted the Genpact Limited 2017 Omnibus

May 10, 2021 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended March 31, 2021 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT L

May 10, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2021 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number

March 26, 2021 EX-5.3

Consent of Appleby (Bermuda) Limited (included in Exhibit 5.3).

Bermuda Office Appleby (Bermuda) Limited Canon?s Court 22 Victoria Street PO Box HM 1179 Hamilton HM EX Bermuda Tel +1 441 295 2244 Appleby (Bermuda) Limited (the Legal Practice) is a company limited by shares incorporated in Bermuda and approved and recognised under the Bermuda Bar (Professional Companies) Rules 2009.

March 26, 2021 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2021 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Numb

March 26, 2021 EX-1.1

Underwriting Agreement, dated as of March 23, 2021, among Genpact Luxembourg and Genpact USA, as co-issuers, Genpact, as guarantor, and Citigroup Global Markets Inc., Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC, as representatives of the Underwriters.

EX-1.1 2 d166844dex11.htm EX-1.1 Exhibit 1.1 EXECUTION VERSION GENPACT LUXEMBOURG S.À R.L. GENPACT USA, INC. GENPACT LIMITED $350,000,000 1.750% Notes due 2026 Underwriting Agreement March 23, 2021 Citigroup Global Markets Inc. Morgan Stanley & Co. LLC Wells Fargo Securities, LLC As Representatives of the several Underwriters c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New Yor

March 26, 2021 EX-4.2

First Supplemental Indenture, dated as of March 26, 2021, by and among the Registrant, Genpact Luxembourg S.à r.l., Genpact USA, Inc. and Wells Fargo Bank, National Association, as trustee, to the Base Indenture dated as of March 26, 2021 (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K (File No. 001-33626) filed with the SEC on March 26, 2021)

Exhibit 4.2 GENPACT LUXEMBOURG S.? R.L. and GENPACT USA, INC. as the Issuers, GENPACT LIMITED, as Guarantor, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as the Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of March 26, 2021 to INDENTURE Dated as of March 26, 2021 Relating to $350,000,000 of 1.750% Notes due 2026 FIRST SUPPLEMENTAL INDENTURE FIRST SUPPLEMENTAL INDENTURE, dated as of March 26, 2021

March 26, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 23, 2021 GENPACT LIMITED (Exact Name of Registrant as Specified in its Charter) Bermuda 001-33626 98-0533350 (State or Other Jurisdiction of Incorporation) (Commission File Numb

March 26, 2021 EX-4.1

r.l., Genpact USA, Inc. and Wells Fargo Bank, National Association, as trustee (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K (File No. 001-33626) filed with the SEC on March 26, 2021).

Exhibit 4.1 GENPACT LUXEMBOURG S.? R.L. and GENPACT USA, INC. as Issuers, GENPACT LIMITED, as Guarantor, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee Indenture Dated as of March 26, 2021 Senior Debt Securities TABLE OF CONTENTS Page ARTICLE ONE DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 101. Definitions 1 SECTION 102. Compliance Certificates and Opinions 9 SECTION

March 26, 2021 EX-4.4

Third Supplemental Indenture, dated as of March 26, 2021, by and among the Registrant, Genpact Luxembourg S.à r.l., Genpact USA, Inc. and Wells Fargo Bank, National Association, as trustee, to the Base Indenture dated as of March 27, 2017 (incorporated by reference to Exhibit 4.4 to the Registrant’s Current Report on Form 8-K (File No. 001-33626) filed with the SEC on March 26, 2021).

EX-4.4 5 d166844dex44.htm EX-4.4 Exhibit 4.4 THIRD SUPPLEMENTAL INDENTURE THIRD SUPPLEMENTAL INDENTURE, dated as of March 26, 2021 (this “Third Supplemental Indenture”), among Genpact Luxembourg S.à r.l., a private limited liability company (société à responsabilité limitée) organized under the laws of the Grand Duchy of Luxembourg registered with the Luxembourg trade and company register under nu

March 25, 2021 DEFA14A

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

March 24, 2021 424B2

Title of Each Class of Securities to be Registered

424B2 1 d101025d424b2.htm 424B2 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Nos. 333-230982 333-230982-01 333-230982-02 Title of Each Class of Securities to be Registered Amount to be Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Amount of Registration Fee (1) 1.750% Senior Notes due 2026 $350,000,000 99.870% $349,545,000 $38,135.

March 24, 2021 DEF 14A

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

March 23, 2021 EX-99.1

Genpact Limited Announces Pricing of 1.750% Senior Notes due 2026 by Genpact Luxembourg S.à r.l. and Genpact USA, Inc.

Exhibit 99.1 Genpact Limited Announces Pricing of 1.750% Senior Notes due 2026 by Genpact Luxembourg S.? r.l. and Genpact USA, Inc. NEW YORK, March 23, 2021 ? Genpact Limited (?Genpact?) (NYSE: G), a global professional services firm focused on delivering digital transformation, today announced the pricing by its wholly owned subsidiaries, Genpact Luxembourg S.? r.l. (?Genpact Luxembourg?) and Gen

March 23, 2021 FWP

GENPACT LUXEMBOURG S.? R.L. GENPACT USA, INC. GENPACT LIMITED $350,000,000 1.750% Senior Notes due 2026 Pricing Term Sheet March 23, 2021

Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Related to the Preliminary Prospectus Supplement dated March 23, 2021 Registration Number 333-230982 GENPACT LUXEMBOURG S.

March 23, 2021 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 23, 2021 GENPACT LIMITED (Exact Name of Registrant as Specified in its Charter) Bermuda 001-33626 98-0533350 (State or Other Jurisdiction of Incorporation) (Commission File Numb

March 23, 2021 424B5

SUBJECT TO COMPLETION, DATED MARCH 23, 2021

424B5 1 d101025d424b5.htm 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Nos. 333-230982 333-230982-01 333-230982-02 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not solicitin

March 23, 2021 EX-4.2

Form of Base Indenture by and among Genpact Luxembourg S.à r.l., Genpact USA, Inc., Genpact Limited and Wells Fargo Bank, National Association, as trustee

Exhibit 4.2 GENPACT LUXEMBOURG S.? R.L. and GENPACT USA, INC. as Issuers, GENPACT LIMITED, as Guarantor, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee Indenture Dated as of [?] Senior Debt Securities TABLE OF CONTENTS Page ARTICLE ONE DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 101. Definitions 1 SECTION 102. Compliance Certificates and Opinions 9 SECTION 103. Form o

March 23, 2021 POSASR

- POSASR

POSASR 1 d118055dposasr.htm POSASR Table of Contents As filed with the Securities and Exchange Commission on March 23, 2021 Registration No. 333-230982 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 2 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermud

March 23, 2021 EX-3.3

Updated and Consolidated Articles of Association of Genpact Luxembourg S.à r.l., dated December 31, 2020

Exhibit 3.3 Registre de Commerce et des Soci?t?s Num?ro RCS : B131149 R?f?rence de d?p?t : L210018074 D?pos? et enregistr? le 29/01/2021 Genpact Luxembourg S. ? r.l. Soci?t? ? responsabilit? limit?e 12F, Rue Guillaume Kroll, L-1882 Luxembourg Grand-Duch? de Luxembourg R.C.S. Luxembourg: B131149 CONSTITUTION: La soci?t? a ?t? constitu?e suivant un acte re?u par Ma?tre Martine Schaeffer, notaire de

March 23, 2021 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 23, 2021 GENPACT LIMITED (Exact Name of Registrant as Specified in its Charter) Bermuda 001-33626 98-0533350 (State or Other Jurisdiction of Incorporation) (Commission File Numb

March 23, 2021 EX-99.1

Supplemental Guarantor Financial Information

EX-99.1 Exhibit 99.1 Supplemental Guarantor Financial Information In connection with the anticipated filing by Genpact Limited (the “Company”) of a Post-Effective Amendment to its Registration Statement on Form S-3 (the “Registration Statement”) for the purpose of adding Genpact USA, Inc. (“Genpact USA”) as an issuer of debt securities and guarantees of debt securities, the Company is providing th

March 23, 2021 EX-5.3

Consent of Appleby (Bermuda) Limited (included in Exhibit 5.3)

Bermuda Office Appleby (Bermuda) Limited Canon?s Court 22 Victoria Street PO Box HM 1179 Hamilton HM EX Bermuda Tel +1 441 295 2244 applebyglobal.

March 23, 2021 EX-3.4

Certificate of Incorporation of Genpact USA, Inc.

EXHIBIT 3.4 CERTIFICATE OF INCORPORATION OF GENPACT USA, INC. FIRST: The name of the corporation is Genpact USA, Inc. (the ?Corporation?). SECOND: The address of the Corporation?s registered office in the State of Delaware is located at 850 New Burton Rd., Suite 201, in the City of Dover, County of Kent, DE 19904. The Corporation?s registered agent at such address is Cogency Global Inc. THIRD: The

March 23, 2021 EX-3.5

By-Laws of Genpact USA, Inc.

EX-3.5 4 d118055dex35.htm EX-3.5 EXHIBIT 3.5 BY-LAWS OF GENPACT USA, INC. TABLE OF CONTENTS ARTICLE I STOCKHOLDERS 1 1.1 Place of Meetings 1 1.2 Annual Meeting 1 1.3 Special Meetings 1 1.4 Notice of Meetings 1 1.5 Voting List 1 1.6 Quorum 2 1.7 Adjournments 2 1.8 Voting and Proxies 2 1.9 Action at Meeting 3 1.10 Conduct of Meetings 3 1. 11 Action without Meeting 4 ARTICLE II DIRECTORS 5 2. 1 Gener

March 23, 2021 EX-25.1

The Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939 by Wells Fargo Bank, National Association (Form T-1)

EX-25.1 10 d118055dex251.htm EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) WELLS FARGO BANK, NATIONAL ASSOCIATION (Exact name of trustee as

March 1, 2021 EX-10.12

Addendum to Employment Agreement by and between Genpact (UK) Limited and N.V. Tyagarajan, dated November 17, 2020 (incorporated by reference to Exhibit 10.12 to the Registrant’s Annual Report on Form 10-K (File No. 001-33626) filed with the SEC on March 1, 2021).

EX-10.12 2 g-ex10121212.htm EX-10.12 Exhibit 10.12 Dear Mr Tyagarajan, Sent by Email Only 17 November 2020 Relocation to the UK: ADDENDUM TO employment contract I am writing to confirm the terms that will apply to your employment contract dated 15 June 2011, and made between yourself and Genpact Limited (a Bermuda limited exempted company) (the Employment Contract), for the duration of your stay i

March 1, 2021 EX-21.1

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of the Registrant: Name: Jurisdiction of Incorporation: Genpact Australia Pty Ltd. Australia Headstrong (Australia) Pty Ltd. Australia Genpact Global (Bermuda) Limited Bermuda Genpact Global Holdings (Bermuda) Limited Bermuda Genpact Brasil Gest?o de Processos Operacionais Ltda. Brazil Enquero Technologies Inc. Canada Genpact Canada Services Company Canada Headstrong Cana

March 1, 2021 10-K

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2020. ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 001-33626 GENPACT LIMITED (Exact na

March 1, 2021 EX-10.16

Master Services Agreement, dated as of December 22, 2016, by and between Genpact International, Inc. and General Electric International, Inc.

Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed.

March 1, 2021 EX-10.13

Employment Agreement by and between Headstrong Canada Company (formerly Headstrong Canada Limited) and Darren Saumur, dated February 26, 2018 (incorporated by reference to Exhibit 10.13 to the Registrant’s Annual Report on Form 10-K (File No. 001-33626) filed with the SEC on March 1, 2021).

Exhibit 10.13 EMPLOYMENT AGREEMENT This Employment Agreement (the ?Agreement?) is made and entered into on February 26, 2018, between Headstrong Canada Limited (the ?Company?) and Darren Saumur ("Employee"). W I T N E S S E T H: WHEREAS, Employee desires to be employed by the Company upon the terms and be subject to the conditions set forth herein. NOW, THEREFORE, in consideration of the foregoing

February 11, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A (Amendment No. 1)* Under the Securities Exchange Act of 1934 GENPACT LIMITED

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A (Amendment No.

February 10, 2021 SC 13G/A

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: Genpact Ltd. Title of Class of Securities: Common Stock CUSIP Number: G3922B107 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1

February 9, 2021 SC 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendme

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* Genpact Ltd. (Name of Issuer) Common Stock (Title of Class of Securities) G3922B107 (CUSIP Number) 12/31/2020 (Date of Event Which Requires

February 9, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2021 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

February 9, 2021 EX-99.1

Genpact Reports Full Year and Fourth Quarter 2020 Results 2020 Total Revenue of $3.7 billion, Up 5% (6% on a constant currency basis)1 2020 Global Client Revenue of $3.3 billion, Up 7%2 2020 Diluted EPS of $1.57, Up 1%; Adjusted Diluted EPS3 of $2.12

Exhibit 99.1 Genpact Reports Full Year and Fourth Quarter 2020 Results 2020 Total Revenue of $3.7 billion, Up 5% (6% on a constant currency basis)1 2020 Global Client Revenue of $3.3 billion, Up 7%2 2020 Diluted EPS of $1.57, Up 1%; Adjusted Diluted EPS3 of $2.12, Up 3% Quarterly Cash Dividend Increased By 10% Board Approves $500 Million Increase to Share Repurchase Program NEW YORK, February 9, 2

February 8, 2021 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10)* GENPACT LTD. (Name of Issuer) (Title of Class of Securities) G3922B107 (CUSIP Number) December 31, 2020

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10)* GENPACT LTD. (Name of Issuer) (Title of Class of Securities) G3922B107 (CUSIP Number) December 31, 2020 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X]

February 3, 2021 SC 13G/A

SCHEDULE 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11 )* Genpact Limited (Name of Issuer) Common Stock (Title of Class of Securities) G3922B107 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched

November 9, 2020 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended September 30, 2020 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPA

November 2, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2020 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

November 2, 2020 EX-99.1

Genpact Reports Third Quarter 2020 Results Total Revenue of $936 million, Up 5%1 Global Client Revenue of $824 million, Up 7%1 2020 Total Revenue now expected to be $3.68 to $3.695 billion, up from the prior range of $3.63 to $3.67 billion

Exhibit 99.1 Genpact Reports Third Quarter 2020 Results Total Revenue of $936 million, Up 5%1 Global Client Revenue of $824 million, Up 7%1 2020 Total Revenue now expected to be $3.68 to $3.695 billion, up from the prior range of $3.63 to $3.67 billion NEW YORK, November 2, 2020 — Genpact Limited (NYSE: G), a global professional services firm focused on delivering digital transformation, today ann

August 10, 2020 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended June 30, 2020 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT LI

August 6, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2020 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Numb

August 6, 2020 EX-99.1

Genpact Reports Second Quarter 2020 Results Total Revenue of $900 million, Up 2% (3% on a constant currency basis)1 Global Client Revenue of $783 million, Up 3% (4% on a constant currency basis)1 Diluted EPS of $0.32, Down 16%; Adjusted Diluted EPS2

EX-99.1 2 g-ex9916.htm EX-99.1 Exhibit 99.1 Genpact Reports Second Quarter 2020 Results Total Revenue of $900 million, Up 2% (3% on a constant currency basis)1 Global Client Revenue of $783 million, Up 3% (4% on a constant currency basis)1 Diluted EPS of $0.32, Down 16%; Adjusted Diluted EPS2 of $0.52, Up 6% NEW YORK, August 6, 2020 — Genpact Limited (NYSE: G), a global professional services firm

May 27, 2020 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2020 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number

May 19, 2020 CORRESP

-

May 19, 2020 Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services Washington, D.

May 11, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2020 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number

May 11, 2020 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended March 31, 2020 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT L

May 11, 2020 EX-99.1

Genpact Reports First Quarter 2020 Results Revenues of $923 million, Up 14% (14% on a constant currency basis)1 Global Client Revenues of $802 million, Up 14% (15% on a constant currency basis)1 Diluted EPS of $0.44, Up 42%; Adjusted Diluted EPS2 of

Exhibit 99.1 Genpact Reports First Quarter 2020 Results Revenues of $923 million, Up 14% (14% on a constant currency basis)1 Global Client Revenues of $802 million, Up 14% (15% on a constant currency basis)1 Diluted EPS of $0.44, Up 42%; Adjusted Diluted EPS2 of $0.53, Up 23% NEW YORK, May 11, 2020 — Genpact Limited (NYSE: G), a global professional services firm focused on delivering digital trans

May 11, 2020 EX-22.1

List of Issuers and Guarantor Subsidiaries (incorporated by reference to Exhibit 22.1 to the Registrant’s Quarterly Report on Form 10-Q (File No. 001-33626) filed with the SEC on May 11, 2020).

Exhibit 22.1 List of Issuers and Guarantor Subsidiaries This table sets forth the issuers and guarantors of the notes issued by Genpact Limited and its subsidiaries and the jurisdiction of incorporation or organization for each such entity. Entity Jurisdiction of Incorporation or Organization 3.70% Senior Notes due 2022 3.375% Senior Notes due 2024 Genpact Limited Bermuda Guarantor Guarantor Genpa

May 7, 2020 DEFA14A

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

April 9, 2020 DEFA14A

G / Genpact Ltd. DEFA14A - - DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

April 9, 2020 DEF 14A

Proxy Statement

DEF 14A 1 g-def14a20200520.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rul

March 2, 2020 10-K

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2019. ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 001-33626 GENPACT LIMITED (Exact na

March 2, 2020 EX-4.7

Description of Registrant’s Securities (incorporated by reference to Exhibit 4.7 to the Registrant’s Annual Report on Form 10-K (File No. 001-33626) filed with the SEC on March 2, 2020).

Exhibit 4.7 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT The following description of registered securities of Genpact Limited is intended as a summary only and therefore is not a complete description. The description is based upon, and is qualified by reference to, our memorandum of association, our bye-laws and applicable provisions of the Companies Act of 1981 (Berm

March 2, 2020 EX-21.1

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of the Registrant: Name: Jurisdiction of Incorporation: Genpact Australia Pty Ltd. Australia Headstrong (Australia) Pty Ltd. Australia Barkawi Management Consultants GmbH, Austria Austria Genpact Global (Bermuda) Limited Bermuda Genpact Global Holdings (Bermuda) Limited Bermuda Genpact Brasil Gestão de Processos Operacionais Ltda. Brazil Headstrong Canada Ltd. Canada Genp

February 26, 2020 8-K

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2020 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File N

February 26, 2020 EX-10.1

Form of Indemnity Agreement for directors and executive officers (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-33626) filed with the SEC on February 26, 2020).

Exhibit 10.1 INDEMNITY AGREEMENT This Indemnification Agreement (“Agreement”) is made as of , by and between Genpact Limited, an exempted company limited by shares incorporated and organized under the laws of Bermuda (“Company”) and [Director/Officer Name] (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve or be employed by publicly-held corporations as

February 14, 2020 SC 13G/A

G / Genpact Ltd. / BROWN ADVISORY INC - BROWN ADVISORY INCORPORATED Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9)* GENPACT LTD. (Name of Issuer) (Title of Class of Securities) G3922B107 (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X]

February 14, 2020 SC 13G/A

G / Genpact Ltd. / HARTFORD MUTUAL FUNDS INC/CT - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1)* Genpact Ltd. (Name of Issuer) Common Stock (Title of Class of Securities) G3922B107 (CUSIP Number) 12/31/2019 (Date of Event Which Requires

February 12, 2020 SC 13G/A

G / Genpact Ltd. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: Genpact Ltd Title of Class of Securities: Common Stock CUSIP Number: G3922B107 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13

February 6, 2020 EX-99.1

Genpact Reports Full Year and Fourth Quarter 2019 Results 2019 Revenues of $3.52 billion, Up 17% (18% on a constant currency basis)1 2019 Global Client BPO Revenues of $2.64 Billion, Up 13% (14% on a constant currency basis)1 2019 Diluted EPS of $1.5

Exhibit 99.1 Genpact Reports Full Year and Fourth Quarter 2019 Results 2019 Revenues of $3.52 billion, Up 17% (18% on a constant currency basis)1 2019 Global Client BPO Revenues of $2.64 Billion, Up 13% (14% on a constant currency basis)1 2019 Diluted EPS of $1.56, Up 8%; 2019 Adjusted Diluted EPS2 of $2.05, Up 14% NEW YORK, February 6, 2020 — Genpact Limited (NYSE: G), a global professional servi

February 6, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2020 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

January 27, 2020 SC 13G/A

G / Genpact Ltd. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10 )* Genpact Limited (Name of Issuer) Common Stock (Title of Class of Securities) G3922B107 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched

November 27, 2019 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 22, 2019 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File N

November 27, 2019 SC 13D/A

G / Genpact Ltd. / Glory Investments B Ltd - SC 13D/A Activist Investment

SC 13D/A 1 d795891dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D UNDER SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 6)* Genpact Limited (Name of Issuer) Common Shares, $0.01 par value per share (Title of Class of Securities) G3922B107 (CUSIP Number) Glory Investments B Limited Suite 110, 10th Floor Ebene Heights Building 34 Ebene Cyberci

November 25, 2019 EX-1.1

Underwriting Agreement, dated November 21, 2019, by and among Genpact Limited, the selling shareholders named in Schedule I thereto and Goldman Sachs & Co. LLC

EX-1.1 2 d836762dex11.htm EX-1.1 Exhibit 1.1 Execution Version 15,430,841 Shares GENPACT LIMITED COMMON SHARES, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT November 21, 2019 November 21, 2019 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 As representative of the several Underwriters Ladies and Gentlemen: Certain shareholders (each a “Selling Shareholder” and collectively, the “Se

November 25, 2019 424B7

CALCULATION OF REGISTRATION FEE Title of Each Class of Securities Offered Amount to be Registered Maximum Offering Price Per Unit Maximum Aggregate Offering Price Amount of Registration Fee(1) Common stock, par value $0.01 per share 15,430,841 $39.95

424B7 1 d837161d424b7.htm FINAL PROSPECTUS SUPPLEMENT Table of Contents Filed Pursuant to Rule 424B7 Registration No. 333-230982 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities Offered Amount to be Registered Maximum Offering Price Per Unit Maximum Aggregate Offering Price Amount of Registration Fee(1) Common stock, par value $0.01 per share 15,430,841 $39.95 $616,462,097.95 $80,

November 25, 2019 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2019 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File N

November 21, 2019 424B7

Prospectus Supplement (To Prospectus dated April 22, 2019) Subject to Completion, dated November 21, 2019 15,430,841 Shares Common Shares

424B7 1 d837161d424b7.htm PRELIMINARY PROSPECTUS SUPPLEMENT Table of Contents Filed Pursuant to Rule 424B7 Registration No. 333-230982 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell the securities nor do they seek an offer to

November 21, 2019 FWP

Genpact Announces Secondary Equity Offering on Behalf of Selling Shareholders

FWP 1 d838463dfwp.htm FWP Filed Pursuant to Rule 433 Registration Statement No. 333-230982 Genpact Announces Secondary Equity Offering on Behalf of Selling Shareholders NEW YORK, November 21, 2019 — Genpact Limited (NYSE: G) (“Genpact”), a global professional services firm focused on delivering digital transformation, today announced an underwritten public offering of 15,430,841 common shares by c

November 18, 2019 EX-1.1

Underwriting Agreement, dated as of November 14, 2019, among Genpact Luxembourg, as issuer, Genpact, as guarantor, and Citigroup Global Markets Inc., Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC, as representatives of the Underwriters.

EX-1.1 Exhibit 1.1 GENPACT LUXEMBOURG S.À R.L. GENPACT LIMITED $400,000,000 3.375% Notes due 2024 Underwriting Agreement November 14, 2019 Citigroup Global Markets Inc. (“Citigroup”) Morgan Stanley & Co. LLC Wells Fargo Securities, LLC As Representatives of the several Underwriters c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 Ladies and Gentlemen: Genpact Luxembo

November 18, 2019 EX-5.3

Consent of Appleby (Bermuda) Limited (included in Exhibit 5.3).

Exhibit 5.3 Genpact Luxembourg S.à r.l. 12F, Rue Guillaume Kroll L-1882 Luxembourg Genpact Limited Victoria Place 5th Floor 31 Victoria Street Hamilton, HM10 Bermuda Email [email protected] Direct Dial +1 441 298 3559 Direct Fax +1 441 298 3469 Tel +1 441 295 2244 Your Ref Appleby Ref 132386.0038/JW 18 November 2019 and Wells Fargo Bank, National Association (Trustee and, together with Gen

November 18, 2019 EX-4.1

Form of 3.375% Senior Note due 2024 (incorporated by reference to Exhibit A to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K (File No. 001-33626) filed with the SEC on November 18, 2019).

EX-4.1 Exhibit 4.1 GENPACT LUXEMBOURG S.À R.L., as the Company, GENPACT LIMITED, as Guarantor, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as the Trustee SECOND SUPPLEMENTAL INDENTURE DATED AS OF November 18, 2019 to INDENTURE DATED AS OF March 27, 2017 Relating to $400,000,000 of 3.375% Notes due 2024 SECOND SUPPLEMENTAL INDENTURE SECOND SUPPLEMENTAL INDENTURE, dated as of November 18, 2019 (this

November 18, 2019 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 14, 2019 GENPACT LIMITED (Exact Name of Registrant as Specified in Charter) Bermuda 001-33626 98-0533350 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

November 18, 2019 424B2

Title of Each Class of Securities to be Registered

Final 424B2 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration No. 333-230982 Title of Each Class of Securities to be Registered Amount to be Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Amount of Registration Fee (1) 3.375% Senior Notes due 2024 $400,000,000 99.976% $399,904,000 $51,920.00 (1) Calculated in accordance with Rule 457(r)

November 15, 2019 EX-99.1

Genpact Limited Announces Pricing of 3.375% Senior Notes due 2024 by Genpact Luxembourg S.à r.l.

EX-99.1 2 d835180dex991.htm EX-99.1 Exhibit 99.1 Genpact Limited Announces Pricing of 3.375% Senior Notes due 2024 by Genpact Luxembourg S.à r.l. NEW YORK, November 14, 2019 – Genpact Limited (“Genpact”) (NYSE: G), a global professional services firm focused on delivering digital transformation, today announced the pricing by its wholly-owned subsidiary, Genpact Luxembourg S.à r.l. (“Genpact Luxem

November 15, 2019 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 14, 2019 GENPACT LIMITED (Exact Name of Registrant as Specified in Charter) Bermuda 001-33626 98-0533350 (State or Other Jurisdiction of Incorporation) (Commission File Numbe

November 14, 2019 FWP

GENPACT LUXEMBOURG S.À R.L. GENPACT LIMITED $400,000,000 3.375% Senior Notes due 2024 Pricing Term Sheet November 14, 2019

FWP Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Relating to the Preliminary Prospectus dated November 14, 2019 Registration Number 333-230982 GENPACT LUXEMBOURG S.

November 14, 2019 POSASR

Powers of Attorney of Genpact Luxembourg S.à r.l. (included in the signature pages to Post-Effective Amendment No. 1 to the Registration Statement)

POSASR 1 d816909dposasr.htm POSASR Table of Contents As filed with the Securities and Exchange Commission on November 14, 2019 Registration No. 333-230982 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GENPACT LIMITED (Exact name of registrant as specified in its charter) Ber

November 14, 2019 EX-25.1

The Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939 by Wells Fargo Bank, National Association (Form T-1)

EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) WELLS FARGO BANK, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) A N

November 14, 2019 EX-5.3

Consent of Appleby (Bermuda) Limited (included in Exhibit 5.3)

EX-5.3 Bermuda Office Appleby (Bermuda) Limited Canon’s Court 22 Victoria Street PO Box HM 1179 Hamilton HM EX Bermuda Tel +1 441 295 2244 applebyglobal.com Appleby (Bermuda) Limited (the Legal Practice) is a company limited by shares incorporated in Bermuda and approved and recognised under the Bermuda Bar (Professional Companies) Rules 2009. “Partner” is a title referring to a director, sharehol

November 14, 2019 424B5

SUBJECT TO COMPLETION, DATED NOVEMBER 14, 2019

424B5 1 d797202d424b5.htm 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Nos. 333-230982 333-230982-01 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to

November 12, 2019 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2019 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

November 8, 2019 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended September 30, 2019 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPA

November 7, 2019 EX-99.1

Genpact Reports Third Quarter 2019 Results Revenues of $889 Million, Up 19%1 Global Client BPO Revenues of $666 Million, Up 14%1 Diluted EPS of $0.45, up 18%; Adjusted Diluted EPS2 of $0.56, up 17%

Exhibit 99.1 Genpact Reports Third Quarter 2019 Results Revenues of $889 Million, Up 19%1 Global Client BPO Revenues of $666 Million, Up 14%1 Diluted EPS of $0.45, up 18%; Adjusted Diluted EPS2 of $0.56, up 17% NEW YORK, November 7, 2019 — Genpact Limited (NYSE: G), a global professional services firm focused on delivering digital transformation, today announced financial results for the third qua

November 7, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2019 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

August 19, 2019 SC 13D/A

G / Genpact Ltd. / Glory Investments B Ltd - SC 13D/A Activist Investment

SC 13D/A 1 d784702dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D UNDER SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5)* Genpact Limited (Name of Issuer) Common Shares, $0.01 par value per share (Title of Class of Securities) G3922B107 (CUSIP Number) Glory Investments B Limited Suite 110, 10th Floor Ebene Heights Building 34 Ebene Cyberci

August 15, 2019 EX-1.1

Underwriting Agreement, dated August 13, 2019, by and among Genpact Limited, the selling shareholders named in Schedule I thereto and Goldman Sachs & Co. LLC

EX-1.1 Exhibit 1.1 12,500,000 Shares GENPACT LIMITED COMMON SHARES, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT August 13, 2019 August 13, 2019 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 As representative of the several Underwriters Ladies and Gentlemen: Certain shareholders (each a “Selling Shareholder” and collectively, the “Selling Shareholders”) named in Schedule I hereto

August 15, 2019 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2019 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Num

August 15, 2019 424B7

CALCULATION OF REGISTRATION FEE Title of Each Class of Securities Offered Amount to be Registered Maximum Offering Price Per Unit Maximum Aggregate Offering Price Amount of Registration Fee(1) Common stock, par value $0.01 per share 12,500,000 $40.59

424B7 1 d790311d424b7.htm FINAL PROSPECTUS SUPPLEMENT Table of Contents Filed Pursuant to Rule 424(b)(7) Registration No. 333-230982 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities Offered Amount to be Registered Maximum Offering Price Per Unit Maximum Aggregate Offering Price Amount of Registration Fee(1) Common stock, par value $0.01 per share 12,500,000 $40.59 $507,375,000 $61

August 13, 2019 424B7

Prospectus Supplement (To Prospectus dated April 22, 2019) Subject to Completion, dated August 13, 2019 12,500,000 Shares Common Shares

Preliminary Prospectus Supplement Table of Contents Filed Pursuant to Rule 424(b)(7) Registration No.

August 13, 2019 FWP

Genpact Announces Secondary Equity Offering on Behalf of Selling Shareholders

FWP 1 d788147dfwp.htm FREE WRITING PROSPECTUS Filed Pursuant to Rule 433 Registration Statement No. 333-230982 Genpact Announces Secondary Equity Offering on Behalf of Selling Shareholders NEW YORK, August 13, 2019 — Genpact Limited (NYSE: G) (“Genpact”), a global professional services firm focused on delivering digital transformation, today announced an underwritten public offering of 12,500,000

August 9, 2019 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended June 30, 2019 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT LI

August 7, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2019 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Numb

August 7, 2019 EX-99.1

Genpact Reports Second Quarter 2019 Results Revenues of $882 Million, Up 21% (~22% on a constant currency basis)1 Global Client BPO Revenues of $659 Million, Up 16% (~17% on a constant currency basis) Diluted EPS of $0.38, up 15%; Adjusted Diluted EP

Exhibit 99.1 Genpact Reports Second Quarter 2019 Results Revenues of $882 Million, Up 21% (~22% on a constant currency basis)1 Global Client BPO Revenues of $659 Million, Up 16% (~17% on a constant currency basis) Diluted EPS of $0.38, up 15%; Adjusted Diluted EPS2 of $0.49, up 20% NEW YORK, August 7, 2019 — Genpact Limited (NYSE: G), a global professional services firm focused on delivering digit

May 28, 2019 SC 13D/A

G / Genpact Ltd. / Glory Investments B Ltd - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D UNDER SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4)* Genpact Limited (Name of Issuer) Common Shares, $0.01 par value per share (Title of Class of Securities) G3922B107 (CUSIP Number) Glory Investments B Limited Suite 110, 10th Floor Ebene Heights Building 34 Ebene Cybercity Ebene, Mauritius (230) 468

May 28, 2019 EX-99.M

AMENDMENT NO. 1 TO THE INVESTOR AGREEMENT

EX-99.M 2 d731384dex99m.htm EX-99.M Exhibit M AMENDMENT NO. 1 TO THE INVESTOR AGREEMENT THIS AMENDMENT NO. 1 to the INVESTOR AGREEMENT (this “Amendment No. 1”) is made as of May 24, 2019, by the undersigned. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Investor Agreement. WHEREAS, Glory Investments A Limited, Glory Investments B Limi

May 23, 2019 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2019 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Nu

May 23, 2019 EX-1.1

Underwriting Agreement, dated May 21, 2019, by and among Genpact Limited, the selling shareholders named in Schedule I thereto and Citigroup Global Markets Inc.

EX-1.1 Exhibit 1.1 EXECUTION VERSION 10,000,000 Shares GENPACT LIMITED COMMON SHARES, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT May 21, 2019 May 21, 2019 Citigroup Global Markets Inc. 388 Greenwich Street New York, NY 10013 As representative of the several Underwriters Ladies and Gentlemen: Certain shareholders (each a “Selling Shareholder” and collectively, the “Selling Shareholders”) name

May 23, 2019 424B7

Calculation of Registration Fee Title of Each Class of Securities to be Registered Amount to be Registered Maximum Offering Price Per Unit Maximum Aggregate Offering Price Amount of Registration Fee(1) Common stock, par value $0.01 per share 10,000,0

Final Prospectus Supplement Table of Contents Filed Pursuant to Rule 424(b)(7) Registration No.

May 21, 2019 424B7

Prospectus Supplement (To Prospectus dated April 22, 2019) Subject to Completion, dated May 21, 2019 10,000,000 Shares Common Shares

424B7 1 d728148d424b7.htm PRELIMINARY PROSPECTUS SUPPLEMENT Table of Contents Filed Pursuant to Rule 424(b)(7) Registration No. 333-230982 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell the securities nor do they seek an offe

May 21, 2019 FWP

Genpact Announces Secondary Equity Offering on Behalf of Selling Shareholders

FWP Filed Pursuant to Rule 433 Registration Statement No. 333-230982 Genpact Announces Secondary Equity Offering on Behalf of Selling Shareholders NEW YORK, May 21, 2019 — Genpact Limited (NYSE: G) (“Genpact”), a global professional services firm focused on delivering digital transformation, today announced an underwritten public offering of 10,000,000 common shares by certain shareholders, consis

May 14, 2019 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2019 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number)

May 10, 2019 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period ended March 31, 2019 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission file number: 001-33626 GENPACT L

May 2, 2019 EX-99.1

Genpact Reports First Quarter 2019 Results Revenues of $809 Million, Up 17% (~19% on a constant currency basis)1 Global Client BPO Revenues of $605 Million, Up 12% (~14% on a constant currency basis) Diluted EPS of $0.31; Adjusted Diluted EPS2 of $0.

Exhibit 99.1 Genpact Reports First Quarter 2019 Results Revenues of $809 Million, Up 17% (~19% on a constant currency basis)1 Global Client BPO Revenues of $605 Million, Up 12% (~14% on a constant currency basis) Diluted EPS of $0.31; Adjusted Diluted EPS2 of $0.43 NEW YORK, May 2, 2019 — Genpact Limited (NYSE: G), a global professional services firm focused on delivering digital transformation, t

May 2, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2019 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number)

April 22, 2019 S-3ASR

G / Genpact Ltd. S-3ASR

S-3ASR Table of Contents As filed with the Securities and Exchange Commission on April 22, 2019 Registration No.

April 22, 2019 EX-4.2

Form of Senior Indenture

EX-4.2 2 d696796dex42.htm EX-4.2 Exhibit 4.2 GENPACT LIMITED and Trustee INDENTURE Dated as of SENIOR DEBT SECURITIES CROSS-REFERENCE TABLE(1) Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 4.04 312(b) 4.04(c) 312(c) 4.04(c) 313(a) 4.03 313(b) 4.03 313(c) 4.03 313(d) 4.

April 22, 2019 EX-4.4

Form of Senior Note

EX-4.4 4 d696796dex44.htm EX-4.4 Exhibit 4.4 Form of Senior Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEP

April 22, 2019 EX-4.5

Form of Subordinated Note

EX-4.5 5 d696796dex45.htm EX-4.5 Exhibit 4.5 Form of Subordinated Note (FACE OF SECURITY) [Each Global Security shall bear substantially the following legend: UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE REGISTERED FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO T

April 22, 2019 EX-4.3

Form of Subordinated Indenture

EX-4.3 3 d696796dex43.htm EX-4.3 Exhibit 4.3 GENPACT LIMITED and Trustee INDENTURE Dated as of SUBORDINATED DEBT SECURITIES CROSS-REFERENCE TABLE(1) Section of Trust Indenture Act of 1939, as amended Section of Indenture 310(a) 6.09 310(b) 6.08 6.10 310(c) Inapplicable 311(a) 6.13 311(b) 6.13 311(c) Inapplicable 312(a) 4.01 312(b) 4.04 312(c) 4.04(c) 313(a) 4.04(c) 313(b) 4.03 313(c) 4.03 312(b) 4

April 10, 2019 DEF 14A

Genpact Limited 2017 Omnibus Incentive Compensation Plan (as amended and restated as of April 5, 2019) (incorporated by reference to Exhibit 1 to the Registrant’s Proxy Statement on Schedule 14A (File No. 001-33626) filed with the SEC on April 10, 2019).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

March 1, 2019 10-K

Form 10-K

10-K 1 g-10k20181231.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2018. ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 001-3

March 1, 2019 EX-21.1

Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of the Registrant: Name: Jurisdiction of Incorporation: Genpact Australia Pty Ltd Australia Headstrong (Australia) Pty Ltd. Australia Barkawi Management Consultants GmbH Austria Genpact Global (Bermuda) Limited Bermuda Genpact Global Holdings (Bermuda) Limited Bermuda Genpact Brasil Gestão de Processos Operacionais Ltda. Brazil Genpact Canada Ltd. Canada Headstrong Canada

March 1, 2019 EX-10.9

Form of Share Option Agreement for executive officers under the Genpact Limited 2017 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.9 to the Registrant’s Annual Report on Form 10-K (File No. 001-33626) filed with the SEC on March 1, 2019).

EX-10.9 5 g-ex1091964.htm EX-10.9 Exhibit 10.9 GENPACT LIMITED 2017 OMNIBUS INCENTIVE COMPENSATION PLAN SHARE OPTION AGREEMENT THIS SHARE OPTION AGREEMENT (the “Agreement”), dated as of (the “Date of Grant”), is made by and between Genpact Limited, an exempted limited company organized under the laws of Bermuda (the “Company”), and (“Participant”). R E C I T A L S: WHEREAS, the Company has adopted

Other Listings
DE:35G € ٣٨٫١٢
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista